Brief: Immunome And Corleen Roche Agreed To A Mutual Separation Effective January 2, 2024
29/12/2023 22:18
Dec 29 (Reuters) - Immunome Inc IMNM.O :
* IMMUNOME INC - ON DECEMBER 22, CO AND CORLEEN ROCHE AGREED
TO A
MUTUAL SEPARATION EFFECTIVE JANUARY 2, 2024
* IMMUNOME INC - EFFECTIVE AS OF ROCHE SEPARATION DATE,
ROCHE WILL
NO LONGER SERVE AS COMPANY'S CHIEF FINANCIAL OFFICER
Further company coverage: IMNM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immunome
See all newsBrief: Immunome - Enters Amendment No. 4 To License Agreement With Bristol-Myers Squibb Company On Oct 2, 2026
US STOCKS ON THE MOVE-Cardinal Health, nVent, Acuity
U.S. STOCKS ON THE MOVE-Cardinal Health, Fervo Energy, Rocket Lab
U.S. STOCKS ON THE MOVE-Progress Software, Vicor Corp, Accenture
Immunome climbs as Stifel initiates coverage